Travis Cossette

Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of <i>MERTK</i> Associated Retinitis Pigmentosa

Thomas J. Conlon, Wen‐Tao Deng, Kirsten Erger et al. · Human Gene Therapy Clinical Development · 2013 · 94 citations · Full text

Ocular Disease, In Vivo Gene Therapy, Aav Vector +21

Enhancing face validity of mouse models of Alzheimer’s disease with natural genetic variation

Kristen D. Onos, Asli Uyar, Kelly J. Keezer et al. · PLoS Genetics · 2019 · 94 citations · Full text

Transgenic Mouse Models, Genetics, Disease Heterogeneity +17

Long-term Preservation of Cone Photoreceptors and Restoration of Cone Function by Gene Therapy in the Guanylate Cyclase-1 Knockout (GC1KO) Mouse

Sanford L. Boye, Thomas J. Conlon, Kirsten Erger et al. · Investigative Ophthalmology & Visual Science · 2011 · 63 citations · Full text

In vivo post-transcriptional gene silencing of α-1 antitrypsin by adeno-associated virus vectors expressing siRNA

Pedro E. Cruz, Christian Mueller, Travis Cossette et al. · Laboratory Investigation · 2007 · 61 citations · Full text

Transcriptional Regulation, α-1 Antitrypsin, Natural Sciences +10

Efficient Hepatic Delivery and Expression from a Recombinant Adeno-associated Virus 8 Pseudotyped α1-Antitrypsin Vector

Thomas J. Conlon, Travis Cossette, Kirsten Erger et al. · Molecular Therapy · 2005 · 54 citations · Full text